SP 10
Access to cancer medicines and targeted therapies in developing countries
Zeba Aziz
Lido
2430
Vezesque se leu este artigo
1168
Total PDF
1262
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 12 | 21 | 14 | 35 |
| 2025 11 | 75 | 32 | 107 |
| 2025 10 | 62 | 12 | 74 |
| 2025 9 | 65 | 26 | 91 |
| 2025 8 | 40 | 17 | 57 |
| 2025 7 | 46 | 31 | 77 |
| 2025 6 | 44 | 21 | 65 |
| 2025 5 | 38 | 13 | 51 |
| 2025 4 | 33 | 10 | 43 |
| 2025 3 | 44 | 12 | 56 |
| 2025 2 | 26 | 20 | 46 |
| 2025 1 | 40 | 19 | 59 |
| 2024 12 | 12 | 16 | 28 |
| 2024 11 | 23 | 19 | 42 |
| 2024 10 | 14 | 18 | 32 |
| 2024 9 | 23 | 20 | 43 |
| 2024 8 | 16 | 27 | 43 |
| 2024 7 | 15 | 17 | 32 |
| 2024 6 | 20 | 18 | 38 |
| 2024 5 | 21 | 24 | 45 |
| 2024 4 | 15 | 18 | 33 |
| 2024 3 | 16 | 16 | 32 |
| 2024 2 | 18 | 21 | 39 |
| 2024 1 | 17 | 23 | 40 |
| 2023 12 | 17 | 14 | 31 |
| 2023 11 | 29 | 33 | 62 |
| 2023 10 | 7 | 14 | 21 |
| 2023 9 | 18 | 22 | 40 |
| 2023 8 | 5 | 11 | 16 |
| 2023 7 | 10 | 5 | 15 |
| 2023 6 | 17 | 20 | 37 |
| 2023 5 | 22 | 18 | 40 |
| 2023 4 | 15 | 2 | 17 |
| 2023 3 | 12 | 12 | 24 |
| 2023 2 | 11 | 13 | 24 |
| 2023 1 | 11 | 8 | 19 |
| 2022 12 | 15 | 14 | 29 |
| 2022 11 | 12 | 15 | 27 |
| 2022 10 | 15 | 18 | 33 |
| 2022 9 | 13 | 19 | 32 |
| 2022 8 | 10 | 22 | 32 |
| 2022 7 | 8 | 20 | 28 |
| 2022 6 | 9 | 20 | 29 |
| 2022 5 | 13 | 16 | 29 |
| 2022 4 | 14 | 28 | 42 |
| 2022 3 | 15 | 14 | 29 |
| 2022 2 | 13 | 23 | 36 |
| 2021 1 | 17 | 16 | 33 |
| 2021 12 | 11 | 20 | 31 |
| 2021 11 | 19 | 25 | 44 |
| 2021 10 | 11 | 27 | 38 |
| 2021 9 | 14 | 22 | 36 |
| 2021 8 | 16 | 32 | 48 |
| 2021 7 | 14 | 23 | 37 |
| 2021 6 | 7 | 17 | 24 |
| 2021 5 | 21 | 28 | 49 |
| 2021 4 | 21 | 24 | 45 |
| 2021 3 | 20 | 33 | 53 |
| 2021 2 | 11 | 12 | 23 |
| 2020 1 | 9 | 17 | 26 |
| 2020 12 | 7 | 13 | 20 |
| 2020 11 | 9 | 14 | 23 |
Mostrar tudo
